The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: A European patient-driven online survey

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2292-2301

  Gordon, Caroline ^a   Isenberg, David ^b   Lerstrøm, Kirsten ^c   Norton, Yvonne ^c   Nikaï, Enkeleida ^d   Pushparajah, Daphnee S ^d   Schneider, Matthias ^e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LUPUS EUROPE ^*  (United Kingdom)

^d UCB PHARMA   (Belgium)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Fatigue; HRQoL; PRO; Productivity; SLE

Indexed keywords

ADULT; AGED; ARTICLE; CAREER; DECISION MAKING; EDUCATIONAL STATUS; EMPLOYMENT; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; SYSTEMIC LUPUS ERYTHEMATOSUS;

FATIGUE; HRQOL; PRO; PRODUCTIVITY; SLE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANALYSIS OF VARIANCE; CAREER CHOICE; COST OF ILLNESS; EFFICIENCY; EMPLOYMENT; EUROPE; FATIGUE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; REGRESSION ANALYSIS; RESIDENCE CHARACTERISTICS; YOUNG ADULT;

EID: 84887715361     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket300     Document Type: Article

References (43)

1. Pons-Estel GJ, Alarcon GS, Scofield L et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68.
2. Eisenberg R. Why can't we find a new treatment for SLE? J Autoimmun 2009;32:223-30.
3. Strand V. Lessons learned from clinical trials in SLE. Autoimmun Rev 2007;6:209-14.
4. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43.
5. Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoecon Outcomes Res 2005;5:317-26.
6. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus:an update. Ann Acad Med Singapore 2007;36:115-22.
7. Bruce IN, Mak VC, Hallett DC et al. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999;58:379-81.
8. Dobkin PL, Da CD, Fortin PR et al. Living with lupus:a prospective pan-Canadian study. J Rheumatol 2001;28:2442-8.
9. Greco CM, Rudy TE, Manzi S. Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus. J Rheumatol 2004;31:260-7.
10. Kiani AN, Petri M. Quality-of-life measurements versus disease activity in systemic lupus erythematosus. Curr Rheumatol Rep 2010;12:250-8.
11. Petri M, Naqibuddin M, Carson KA et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol 2008;35:1776-81.
12. Gordon C, Clarke AE. Quality of life and economic evaluation in SLE clinical trials. Lupus 1999;8:645-54.
13. Jolly M. Pitfalls and opportunities in measuring patient outcomes in lupus. Curr Rheumatol Rep 2010;12:229-36.
14. Strand V, Gladman D, Isenberg D et al. Endpoints:consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus 2000;9:322-7.
15. Stoll T, Gordon C, Seifert B et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997;24:1608-14.
16. Fortin PR, Abrahamowicz M, Neville C et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998;7:101-7.
17. Yee CS, McElhone K, Teh LS et al. Assessment of disease activity and quality of life in systemic lupus erythematosus- new aspects. Best Pract Res Clin Rheumatol 2009;23:457-67.
18. McElhone K, Abbott J, Shelmerdine J et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007;57:972-9.
19. Krupp LB, LaRocca NG, Muir J et al. A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990;17:1450-2.
20. Zonana-Nacach A, Roseman JM, McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations:NAture vs Nurture. Lupus 2000;9:101-9.
21. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue on SLE:a systemic review. Arthritis Rheum 2007;57:1348-57.
22. Baker K, Pope J. Employment and work disability in systemic lupus erythematosus:a systematic review. Rheumatology 2009;48:281-4.
23. Yelin E, Trupin L, Katz P et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
24. Panopalis P, Petri M, Manzi S et al. The systemic lupus erythematosus Tri-Nation study:cumulative indirect costs. Arthritis Rheum 2007;57:64-70.
25. Lerstrøm L, Crimmings M, Govoni M et al. Impact of systemic lupus erythematosus on patients' employment, family relationships and overall well-being. EULAR 2010; Poster PARE0003.
26. Crimmings M, Lerstrom K, Govoni M et al. Impact of lupus on patients' employment, family relationships and overall well-being. Presented at:ACR 2010:Poster PO1 F.9.
27. Krupp LB, LaRocca NG, Muir-Nash J et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
28. Chen H, Blanc PD, Hayden ML et al. Assessing productivity loss and activity impairment in severe or difficult-totreat asthma. Value Health 2008;11:231-9.
29. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-65.
30. Reilly MC, Gooch KL, Wong RL et al. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology 2010;49:812-9.
31. Zhang W, Bansback N, Boonen A et al. Validity of the work productivity and activity impairment questionnaire-general health version in patients with rheumatoid arthritis. Arthritis Res Ther 2010;12: R177.
32. Reilly Associates. WPAI:SHP v2.0. http://www.reillyas sociates.net/WPAI_SHP.html (15 August 2013, date last accessed).
33. Touma Z, Gladman DD, Ibanez D et al. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? J Rheumatol 2011;38:1898-905.
34. Strand V, Chu AD. Generic versus disease-specific measures of health-related quality of life in systemic lupus erythematosus. J Rheumatol 2011;38:1821-3.
35. Burgos PI, Alarcon GS, McGwin G Jr et al. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort:LXVII. Arthritis Rheum 2009;61:1179-86.
36. Huscher D, Merkesdal S, Thiele K et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006;65:1175-83.
37. Bultink IE, Turkstra F, Dijkmans BA et al. High prevalence of unemployment in patients with systemic lupus erythematosus:association with organ damage and health-related quality of life. J Rheumatol 2008;35:1053-7.
38. Nived O, Andersson M, Lindgren M et al. Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed:a study with a questionnaire. Lupus 2007;16:701-6.
39. Jonsen A, Bengtsson AA, Nived O et al. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population:increased morbidity but low mortality. Rheumatology 2002;41:1308-12.
40. Mau W, Listing J, Huscher D et al. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005;32:721-8.
41. Boomsma MM, Bijl M, Stegeman CA et al. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum 2002;47:196-201.
42. Sutcliffe N, Clarke AE, Taylor R et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology 2001;40:37-47.
43. Clarke AE, Penrod J, St Pierre Y et al. Underestimating the value of women:assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol 2000;27:2597-604.